Minor haemorrhage · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
Self‐monitoring of oral anticoagulation showed no clear difference in minor haemorrhage compared with standard care (moderate certainty).
1 finding from 1 review
Thromboembolic events · Patients on long‐term anticoagulant therapy (treatment duration longer than two months) irrespective of the indication for treatment
self‐management of oral anticoagulation probably leads to lower thromboembolic events compared with standard care (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention showed no clear difference in all‐cause mortality Median (low certainty).
1 finding from 1 review
Intervention not reported
ASCVD event, such as fatal or non‐fatal myocardial infarction or stroke. Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention showed no clear difference in ASCVD event, such as fatal or non‐fatal myocardial infarction or… (low certainty).
1 finding from 1 review
Intervention not reported
Any investigator‐defined adverse event Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention probably leads to higher any investigator‐defined adverse event Median (moderate certainty).
1 finding from 1 review
Intervention not reported
Systolic blood pressure, mmHg Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
Total cholesterol, mmol/L Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
LDL cholesterol, mmol/L Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
1 finding from 1 review
Intervention not reported
Adherence, variable definitions Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention probably leads to higher adherence, variable definitions Median (moderate certainty).
1 finding from 1 review
All‐cause mortality in hospital for participants with AMI · patients with acute myocardial infarction
It is very uncertain whether oxygen changes all‐cause mortality in hospital for participants with AMI compared with air (very low certainty).
1 finding from 1 review
All‐cause mortality in hospital for all participants (including those without confirmed AMI) · patients with acute myocardial infarction
It is very uncertain whether oxygen changes all‐cause mortality in hospital for all participants (including… compared with air (very low certainty).
1 finding from 1 review
All‐cause mortality in hospital for all participants (including those without confirmed AMI) trials done in the revascularisation era · patients with acute myocardial infarction
Oxygen showed no clear difference in all‐cause mortality in hospital for all participants (including… compared with air (low certainty).
1 finding from 1 review
Opiate use (as a proxy measure for pain) for all participants on ITT (including those without confirmed AMI) · patients with acute myocardial infarction
Oxygen showed no clear difference in opiate use (as a proxy measure for pain) for all participants on ITT… compared with air (low certainty).
1 finding from 1 review
Recurrent myocardial infarction (or ischaemia) · patients with acute myocardial infarction
Oxygen showed no clear difference in recurrent myocardial infarction (or ischaemia) compared with air (low certainty).
1 finding from 1 review
Infarct size CK and other enzymes · patients with acute myocardial infarction
1 finding from 1 review
Infarct size by MRI (estimated 6 months after AMI) · patients with acute myocardial infarction
1 finding from 1 review
Intervention not reported
Mortality (all cause) Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower mortality (all cause) Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Periprocedural adverse events · people with chronic ischaemic heart disease and congestive heart failure
1 finding from 1 review
Intervention not reported
Non‐fatal myocardial infarction Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower non‐fatal myocardial infarction Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Rehospitalisation due to heart failure Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention showed no clear difference in rehospitalisation due to heart failure Long‐term (low certainty).
1 finding from 1 review